{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:20:33Z","timestamp":1791937233925,"version":"4.3.4"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T00:00:00Z","timestamp":1629331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T00:00:00Z","timestamp":1629331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010663","name":"H2020 European Research Council","doi-asserted-by":"publisher","award":["666918"],"award-info":[{"award-number":["666918"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["PID2019\u2010105699RB\u2010I00"],"award-info":[{"award-number":["PID2019\u2010105699RB\u2010I00"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["RED2018\u2010102576\u2010T"],"award-info":[{"award-number":["RED2018\u2010102576\u2010T"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016658","name":"Plan Nacional sobre Drogas","doi-asserted-by":"publisher","award":["2020I028"],"award-info":[{"award-number":["2020I028"]}],"id":[{"id":"10.13039\/100016658","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014180","name":"Junta de Castilla y Le\u00f3n","doi-asserted-by":"publisher","award":["CLU\u20102017\u201003"],"award-info":[{"award-number":["CLU\u20102017\u201003"]}],"id":[{"id":"10.13039\/501100014180","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FOR2625"],"award-info":[{"award-number":["FOR2625"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009187","name":"Medical Research Foundation","doi-asserted-by":"publisher","award":["MC_U12266B"],"award-info":[{"award-number":["MC_U12266B"]}],"id":[{"id":"10.13039\/501100009187","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"published-print":{"date-parts":[[2021,10,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Batten diseases (BDs) are a group of lysosomal storage disorders characterized by seizure, visual loss, and cognitive and motor deterioration. We discovered increased levels of globotriaosylceramide (Gb3) in cellular and murine models of CLN3 and CLN7 diseases and used fluorescent\u2010conjugated bacterial toxins to label Gb3 to develop a cell\u2010based high content imaging (HCI) screening assay for the repurposing of FDA\u2010approved compounds able to reduce this accumulation within BD cells. We found that tamoxifen reduced the lysosomal accumulation of Gb3 in CLN3 and CLN7 cell models, including neuronal progenitor cells (NPCs) from CLN7 patient\u2010derived induced pluripotent stem cells (iPSC). Here, tamoxifen exerts its action through a mechanism that involves activation of the transcription factor EB (TFEB), a master gene of lysosomal function and autophagy.\n                    <jats:italic>In vivo<\/jats:italic>\n                    administration of tamoxifen to the CLN7\n                    <jats:sup>\u0394ex2<\/jats:sup>\n                    mouse model reduced the accumulation of Gb3 and SCMAS, decreased neuroinflammation, and improved motor coordination. These data strongly suggest that tamoxifen may be a suitable drug to treat some types of Batten disease.\n                  <\/jats:p>","DOI":"10.15252\/emmm.202013742","type":"journal-article","created":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T15:23:16Z","timestamp":1629386596000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Repurposing of tamoxifen ameliorates CLN3 and CLN7 disease phenotype"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7208-857X","authenticated-orcid":false,"given":"Chiara","family":"Soldati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3049-748X","authenticated-orcid":false,"given":"Irene","family":"Lopez\u2010Fabuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca G","family":"Wanderlingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3908-9060","authenticated-orcid":false,"given":"Marina","family":"Garcia\u2010Macia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jlenia","family":"Monfregola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"Napolitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5334-3344","authenticated-orcid":false,"given":"Marta","family":"Guevara\u2010Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Scotto Rosato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8232-5498","authenticated-orcid":false,"given":"Einar K","family":"Krogsaeter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2065-1639","authenticated-orcid":false,"given":"Dominik","family":"Paquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0177-5559","authenticated-orcid":false,"given":"Christian M","family":"Grimm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Montefusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Braulke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Storch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara E","family":"Mole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0053-3061","authenticated-orcid":false,"given":"Maria A","family":"De Matteis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1381-4604","authenticated-orcid":false,"given":"Andrea","family":"Ballabio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio L","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan","family":"McKay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2168-0004","authenticated-orcid":false,"given":"Ludger","family":"Johannes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3949-6862","authenticated-orcid":false,"given":"Juan P","family":"Bola\u00f1os","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7347-2645","authenticated-orcid":false,"given":"Diego L","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,19]]},"reference":[{"key":"BFEMMM202013742_CR1","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1172\/JCI9711","volume":"105","author":"A Abe","year":"2000","unstructured":"Abe A, Gregory S, Lee L, Killen PD, Brady RO, Kulkarni A, Shayman JA (2000) Reduction of globotriaosylceramide in Fabry disease mice by substrate deprivation. J Clin Invest 105: 1563\u20131571","journal-title":"J Clin Invest"},{"key":"BFEMMM202013742_CR2","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.3390\/cancers13061252","volume":"13","author":"C Actis","year":"2021","unstructured":"Actis C, Muzio G, Autelli R (2021) Autophagy triggers tamoxifen resistance in human breast cancer cells by preventing drug\u2010induced lysosomal damage. Cancers 13: 1252","journal-title":"Cancers"},{"key":"BFEMMM202013742_CR3","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.1073\/pnas.96.8.4432","volume":"96","author":"N Altan","year":"1999","unstructured":"Altan N, Chen Y, Schindler M, Simon SM (1999) Tamoxifen inhibits acidification in cells independent of the estrogen receptor. Proc Natl Acad Sci USA 96: 4432\u20134437","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMMM202013742_CR4","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3171\/2010.8.JNS09352","volume":"114","author":"AS Boulos","year":"2011","unstructured":"Boulos AS, Deshaies EM, Dalfino JC, Feustel PJ, Popp AJ, Drazin D (2011) Tamoxifen as an effective neuroprotectant in an endovascular canine model of stroke. J Neurosurg 114: 1117\u20131126","journal-title":"J Neurosurg"},{"key":"BFEMMM202013742_CR5","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nrneurol.2013.163","volume":"9","author":"R\u2010MN Boustany","year":"2013","unstructured":"Boustany R\u2010MN (2013) Lysosomal storage diseases\u2013the horizon expands. Nat Rev Neurol 9: 583\u2013598","journal-title":"Nat Rev Neurol"},{"key":"BFEMMM202013742_CR6","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/hmg\/ddv615","volume":"25","author":"L Brandenstein","year":"2016","unstructured":"Brandenstein L, Schweizer M, Sedlacik J, Fiehler J, Storch S (2016) Lysosomal dysfunction and impaired autophagy in a novel mouse model deficient for the lysosomal membrane protein Cln7. Hum Mol Genet 25: 777\u2013791","journal-title":"Hum Mol Genet"},{"key":"BFEMMM202013742_CR7","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1093\/hmg\/11.22.2709","volume":"11","author":"SL Cotman","year":"2002","unstructured":"Cotman SL, Vrbanac V, Lebel L\u2010A, Lee RL, Johnson KA, Donahue L\u2010R, Teed AM, Antonellis K, Bronson RT, Lerner TJ et\u00a0al (2002) Cln3 \u0394ex7\/8 knock\u2010in mice with the common JNCL mutation exhibit progressive neurologic disease that begins before birth. Hum Mol Genet 11: 2709\u20132721","journal-title":"Hum Mol Genet"},{"key":"BFEMMM202013742_CR8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.nbd.2014.01.003","volume":"65","author":"M Damme","year":"2014","unstructured":"Damme M, Brandenstein L, Fehr S, Jankowiak W, Bartsch U, Schweizer M, Hermans\u2010Borgmeyer I, Storch S (2014) Gene disruption of Mfsd8 in mice provides the first animal model for CLN7 disease. Neurobiol Dis 65: 12\u201324","journal-title":"Neurobiol Dis"},{"key":"BFEMMM202013742_CR9","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1093\/hmg\/ddy076","volume":"27","author":"T Danyukova","year":"2018","unstructured":"Danyukova T, Ariunbat K, Thelen M, Brocke\u2010Ahmadinejad N, Mole SE, Storch S (2018) Loss of CLN7 results in depletion of soluble lysosomal proteins and impaired mTOR reactivation. Hum Mol Genet 27: 1711\u20131722","journal-title":"Hum Mol Genet"},{"key":"BFEMMM202013742_CR10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1515\/IJAMH.2003.15.4.359","volume":"15","author":"O Derman","year":"2003","unstructured":"Derman O, Kanbur NO, Kutluk T (2003) Tamoxifen treatment for pubertal gynecomastia. Int J Adolesc Med Health 15: 359\u2013363","journal-title":"Int J Adolesc Med Health"},{"key":"BFEMMM202013742_CR11","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1007\/s00018-008-7581-9","volume":"65","author":"KL Double","year":"2008","unstructured":"Double KL, Dedov VN, Fedorow H, Kettle E, Halliday GM, Garner B, Brunk UT (2008) The comparative biology of neuromelanin and lipofuscin in the human brain. Cell Mol Life Sci 65: 1669\u20131682","journal-title":"Cell Mol Life Sci"},{"key":"BFEMMM202013742_CR12","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.neuint.2011.02.003","volume":"58","author":"R Finn","year":"2011","unstructured":"Finn R, Kov\u00e1cs AD, Pearce DA (2011) Altered sensitivity of cerebellar granule cells to glutamate receptor overactivation in the Cln3(\u0394ex7\/8)\u2010knock\u2010in mouse model of juvenile neuronal ceroid lipofuscinosis. Neurochem Int 58: 648\u2013655","journal-title":"Neurochem Int"},{"key":"BFEMMM202013742_CR13","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/j.stemcr.2018.03.015","volume":"10","author":"LM FitzPatrick","year":"2018","unstructured":"FitzPatrick LM, Hawkins KE, Delhove JMKM, Fernandez E, Soldati C, Bullen LF, Nohturfft A, Waddington SN, Medina DL, Bola\u00f1os JP et\u00a0al (2018) NF\u2010\u03baB activity initiates human ESC\u2010derived neural progenitor cell differentiation by inducing a metabolic maturation program. Stem Cell Rep 10: 1766\u20131781","journal-title":"Stem Cell Rep"},{"key":"BFEMMM202013742_CR14","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1038\/s41467-018-07058-4","volume":"9","author":"E Gayi","year":"2018","unstructured":"Gayi E, Neff LA, Massana Mu\u00f1oz X, Ismail HM, Sierra M, Mercier T, D\u00e9costerd LA, Laporte J, Cowling BS, Dorchies OM et\u00a0al (2018) Tamoxifen prolongs survival and alleviates symptoms in mice with fatal X\u2010linked myotubular myopathy. Nat Commun 9: 4848","journal-title":"Nat Commun"},{"key":"BFEMMM202013742_CR15","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.bbadis.2012.08.012","volume":"1832","author":"M Haltia","year":"2013","unstructured":"Haltia M, Goebel HH (2013) The neuronal ceroid\u2010lipofuscinoses: a historical introduction. Biochim Biophys Acta 1832: 1795\u20131800","journal-title":"Biochim Biophys Acta"},{"key":"BFEMMM202013742_CR16","doi-asserted-by":"crossref","first-page":"165614","DOI":"10.1016\/j.bbadis.2019.165614","volume":"1866","author":"RJ Huber","year":"2020","unstructured":"Huber RJ, Hughes SM, Liu W, Morgan A, Tuxworth RI, Russell C (2020) The contribution of multicellular model organisms to neuronal ceroid lipofuscinosis research. Biochim Biophys Acta 1866: 165614","journal-title":"Biochim Biophys Acta"},{"key":"BFEMMM202013742_CR17","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.bbamcr.2018.07.017","volume":"1865","author":"RJ Huber","year":"2018","unstructured":"Huber RJ, Mathavarajah S (2018) Secretion and function of Cln5 during the early stages of Dictyostelium development. Biochim Biophys Acta Mol Cell Res 1865: 1437\u20131450","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"BFEMMM202013742_CR18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.mce.2008.03.005","volume":"289","author":"A Kallio","year":"2008","unstructured":"Kallio A, Guo T, Lamminen E, Sepp\u00e4nen J, Kangas L, V\u00e4\u00e4n\u00e4nen HK, H\u00e4rk\u00f6nen P (2008) Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells. Mol Cell Endocrinol 289: 38\u201348","journal-title":"Mol Cell Endocrinol"},{"key":"BFEMMM202013742_CR19","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0167-4943(02)00005-5","volume":"34","author":"ML Katz","year":"2002","unstructured":"Katz ML, Robison WG (2002) What is lipofuscin? Defining characteristics and differentiation from other autofluorescent lysosomal storage bodies. Arch Gerontol Geriatr 34: 169\u2013184","journal-title":"Arch Gerontol Geriatr"},{"key":"BFEMMM202013742_CR20","doi-asserted-by":"crossref","first-page":"165553","DOI":"10.1016\/j.bbadis.2019.165553","volume":"1866","author":"V Kauss","year":"2020","unstructured":"Kauss V, Dambrova M, Medina DL (2020) Pharmacological approaches to tackle NCLs. Biochim Biophys Acta Mol Basis Dis 1866: 165553","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"BFEMMM202013742_CR21","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2174\/157488908784534603","volume":"3","author":"HK Kimelberg","year":"2008","unstructured":"Kimelberg HK (2008) Tamoxifen as a powerful neuroprotectant in experimental stroke and implications for human stroke therapy. Recent Pat CNS Drug Discov 3: 104\u2013108","journal-title":"Recent Pat CNS Drug Discov"},{"key":"BFEMMM202013742_CR22","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3171\/jns.2003.99.1.0138","volume":"99","author":"HK Kimelberg","year":"2003","unstructured":"Kimelberg HK, Jin Y, Charniga C, Feustel PJ (2003) Neuroprotective activity of tamoxifen in permanent focal ischemia. J Neurosurg 99: 138\u2013142","journal-title":"J Neurosurg"},{"key":"BFEMMM202013742_CR23","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.nbd.2005.12.018","volume":"22","author":"AD Kov\u00e1cs","year":"2006","unstructured":"Kov\u00e1cs AD, Weimer JM, Pearce DA (2006) Selectively increased sensitivity of cerebellar granule cells to AMPA receptor\u2010mediated excitotoxicity in a mouse model of Batten disease. Neurobiol Dis 22: 575\u2013585","journal-title":"Neurobiol Dis"},{"key":"BFEMMM202013742_CR24","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1542\/peds.2005-0577","volume":"116","author":"NC Kreher","year":"2005","unstructured":"Kreher NC, Eugster EA, Shankar RR (2005) The use of tamoxifen to improve height potential in short pubertal boys. Pediatrics 116: 1513\u20131515","journal-title":"Pediatrics"},{"key":"BFEMMM202013742_CR25","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante M, Sabatini DM (2012) mTOR signaling in growth control and disease. Cell 149: 274\u2013293","journal-title":"Cell"},{"key":"BFEMMM202013742_CR26","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1074\/jbc.272.3.1682","volume":"272","author":"Y Lavie","year":"1997","unstructured":"Lavie Y, Cao H\u2010T, Volner A, Lucci A, Han T\u2010Y, Geffen V, Giuliano AE, Cabot MC (1997) Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells. J Biol Chem 272: 1682\u20131687","journal-title":"J Biol Chem"},{"key":"BFEMMM202013742_CR27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jpeds.2004.03.057","volume":"145","author":"SE Lawrence","year":"2004","unstructured":"Lawrence SE, Faught KA, Vethamuthu J, Lawson ML (2004) Beneficial effects of raloxifene and tamoxifen in the treatment of pubertal gynecomastia. J Pediatr 145: 71\u201376","journal-title":"J Pediatr"},{"key":"BFEMMM202013742_CR28","volume":"8","author":"CA Lieu","year":"2013","unstructured":"Lieu CA, Chinta SJ, Rane A, Andersen JK (2013) Age\u2010related behavioral phenotype of an astrocytic monoamine oxidase\u2010B transgenic mouse model of Parkinson\u2019s disease. PLoS One 8: e54200","journal-title":"PLoS One"},{"key":"BFEMMM202013742_CR29","doi-asserted-by":"crossref","first-page":"13063","DOI":"10.1073\/pnas.1613701113","volume":"113","author":"I Lopez\u2010Fabuel","year":"2016","unstructured":"Lopez\u2010Fabuel I, Douce JL, Logan A, James AM, Bonvento G, Murphy MP, Almeida A, Bola\u00f1os JP (2016) Complex I assembly into supercomplexes determines differential mitochondrial ROS production in neurons and astrocytes. Proc Natl Acad Sci USA 113: 13063\u201313068","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMMM202013742_CR30","volume":"12","author":"S Lu","year":"2017","unstructured":"Lu S, Sung T, Lin N, Abraham RT, Jessen BA (2017) Lysosomal adaptation: How cells respond to lysosomotropic compounds. PLoS One 12: e0173771","journal-title":"PLoS One"},{"key":"BFEMMM202013742_CR31","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0165-5876(93)90053-6","volume":"25","author":"J Maddalozzo","year":"1993","unstructured":"Maddalozzo J, Tenta LT, Hutchinson LR, Crawford SE, Morse DS (1993) Juvenile fibromatosis: hormonal receptors. Int J Pediatr Otorhinolaryngol 25: 191\u2013199","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"BFEMMM202013742_CR32","first-page":"209","volume-title":"E.\u00a0coli: Shiga toxin methods and protocols","author":"F Mallard","year":"2003","unstructured":"Mallard F, Johannes L (2003) Shiga toxin B\u2010subunit as a tool to study retrograde transport, In Philpott D, Ebel F (eds.), E.\u00a0coli: Shiga toxin methods and protocols pp 209\u2013220., Totowa, NJ: Humana Press"},{"key":"BFEMMM202013742_CR33","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.devcel.2011.07.016","volume":"21","author":"D Medina","year":"2011","unstructured":"Medina D, Fraldi A, Bouche V, Annunziata F, Mansueto G, Spampanato C, Puri C, Pignata A, Martina J, Sardiello M et\u00a0al (2011) Transcriptional activation of lysosomal exocytosis promotes cellular clearance. Dev Cell 21: 421\u2013430","journal-title":"Dev Cell"},{"key":"BFEMMM202013742_CR34","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S1474-4422(14)70151-6","volume":"13","author":"SE Mole","year":"2014","unstructured":"Mole SE (2014) Development of new treatments for Batten disease. Lancet Neurol 13: 749\u2013751","journal-title":"Lancet Neurol"},{"key":"BFEMMM202013742_CR35","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1474-4422(18)30368-5","volume":"18","author":"SE Mole","year":"2019","unstructured":"Mole SE, Anderson G, Band HA, Berkovic SF, Cooper JD, Kleine Holthaus S\u2010M, McKay TR, Medina DL, Rahim AA, Schulz A et\u00a0al (2019) Clinical challenges and future therapeutic approaches for neuronal ceroid lipofuscinosis. Lancet Neurol 18: 107\u2013116","journal-title":"Lancet Neurol"},{"key":"BFEMMM202013742_CR36","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.bbadis.2015.05.011","volume":"1852","author":"SE Mole","year":"2015","unstructured":"Mole SE, Cotman SL (2015) Genetics of the neuronal ceroid lipofuscinoses (Batten disease). Biochim Biophys Acta 1852: 2237\u20132241","journal-title":"Biochim Biophys Acta"},{"key":"BFEMMM202013742_CR37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10048-005-0218-3","volume":"6","author":"SE Mole","year":"2005","unstructured":"Mole SE, Williams RE, Goebel HH (2005) Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses. Neurogenetics 6: 107\u2013126","journal-title":"Neurogenetics"},{"key":"BFEMMM202013742_CR38","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.bbalip.2015.05.001","volume":"1851","author":"SAF Morad","year":"2015","unstructured":"Morad SAF, Cabot MC (2015) Tamoxifen regulation of sphingolipid metabolism\u2013therapeutic implications. Biochim Biophys Acta 1851, 1134\u20131145","journal-title":"Biochim Biophys Acta"},{"key":"BFEMMM202013742_CR39","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/7b2c04df-8592-4fb7-8608-3039db28b504","volume":"7","author":"M Namdar","year":"2012","unstructured":"Namdar M, Gebhard C, Studiger R, Shi Y, Mocharla P, Schmied C, Brugada P, L\u00fcscher TF, Camici GG (2012) Globotriaosylsphingosine accumulation and not alpha\u2010galactosidase\u2010A deficiency causes endothelial dysfunction in Fabry disease. PLoS One 7: e36373","journal-title":"PLoS One"},{"key":"BFEMMM202013742_CR40","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41586-020-2444-0","volume":"585","author":"G Napolitano","year":"2020","unstructured":"Napolitano G, Di Malta C, Esposito A, de Araujo MEG, Pece S, Bertalot G, Matarese M, Benedetti V, Zampelli A, Stasyk T et\u00a0al (2020) A substrate\u2010specific mTORC1 pathway underlies Birt\u2013Hogg\u2013Dub\u00e9 syndrome. Nature 585: 597\u2013602","journal-title":"Nature"},{"key":"BFEMMM202013742_CR41","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1083\/jcb.90.3.656","volume":"90","author":"S Ohkuma","year":"1981","unstructured":"Ohkuma S, Poole B (1981) Cytoplasmic vacuolation of mouse peritoneal macrophages and the uptake into lysosomes of weakly basic substances. J Cell Biol 90: 656\u2013664","journal-title":"J Cell Biol"},{"key":"BFEMMM202013742_CR42","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1016\/j.bbadis.2015.06.014","volume":"1852","author":"DN Palmer","year":"2015","unstructured":"Palmer DN (2015) The relevance of the storage of subunit c of ATP synthase in different forms and models of Batten disease (NCLs). Biochim Biophys Acta 1852: 2287\u20132291","journal-title":"Biochim Biophys Acta"},{"key":"BFEMMM202013742_CR43","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.2174\/1389200218666170925125940","volume":"18","author":"S Pisonero\u2010Vaquero","year":"2017","unstructured":"Pisonero\u2010Vaquero S, Medina DL (2017) Lysosomotropic drugs: pharmacological tools to study lysosomal function. Curr Drug Metab 18: 1147\u20131158","journal-title":"Curr Drug Metab"},{"key":"BFEMMM202013742_CR44","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neurobiolaging.2016.08.004","volume":"48","author":"A\u2010A Poirier","year":"2016","unstructured":"Poirier A\u2010A, C\u00f4t\u00e9 M, Bourque M, Morissette M, Di Paolo T, Soulet D (2016) Neuroprotective and immunomodulatory effects of raloxifene in the myenteric plexus of a mouse model of Parkinson\u2019s disease. Neurobiol Aging 48: 61\u201371","journal-title":"Neurobiol Aging"},{"key":"BFEMMM202013742_CR45","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1006\/mgme.1999.2834","volume":"66","author":"KL Puranam","year":"1999","unstructured":"Puranam KL, Guo W\u2010X, Qian W\u2010H, Nikbakht K, Boustany R\u2010M (1999) CLN3 defines a novel antiapoptotic pathway operative in neurodegeneration and mediated by ceramide. Mol Genet Metab 66: 294\u2013308","journal-title":"Mol Genet Metab"},{"key":"BFEMMM202013742_CR46","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1600-0854.2009.00919.x","volume":"10","author":"H Raa","year":"2009","unstructured":"Raa H, Grimmer S, Schwudke D, Bergan J, W\u00e4lchli S, Skotland T, Shevchenko A, Sandvig K (2009) Glycosphingolipid requirements for endosome\u2010to\u2010Golgi transport of Shiga toxin. Traffic 10: 868\u2013882","journal-title":"Traffic"},{"key":"BFEMMM202013742_CR47","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1055\/s-2008-1071470","volume":"21","author":"R Raininko","year":"1990","unstructured":"Raininko R, Santavuori P, Heiskala H, Sainio K, Palo J (1990) CT findings in neuronal ceroid lipofuscinoses. Neuropediatrics 21: 95\u2013101","journal-title":"Neuropediatrics"},{"key":"BFEMMM202013742_CR48","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1203\/PDR.0b013e31816fdc17","volume":"63","author":"E Rusyn","year":"2008","unstructured":"Rusyn E, Mousallem T, Persaud\u2010Sawin D\u2010A, Miller S, Boustany R\u2010MN (2008) CLN3p impacts galactosylceramide transport, raft morphology, and lipid content. Pediatr Res 63: 625\u2013631","journal-title":"Pediatr Res"},{"key":"BFEMMM202013742_CR49","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1073\/pnas.1019267108","volume":"108","author":"JL Sampaio","year":"2011","unstructured":"Sampaio JL, Gerl MJ, Klose C, Ejsing CS, Beug H, Simons K, Shevchenko A (2011) Membrane lipidome of an epithelial cell line. Proc Natl Acad Sci USA 108: 1903\u20131907","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMMM202013742_CR50","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.1174447","volume":"325","author":"M Sardiello","year":"2009","unstructured":"Sardiello M, Palmieri M, di Ronza A, Medina DL, Valenza M, Gennarino VA, Di Malta C, Donaudy F, Embrione V, Polishchuk RS et\u00a0al (2009) A gene network regulating lysosomal biogenesis and function. Science 325: 473\u2013477","journal-title":"Science"},{"key":"BFEMMM202013742_CR51","doi-asserted-by":"crossref","first-page":"9592","DOI":"10.1074\/jbc.RA119.008852","volume":"294","author":"C Schmidtke","year":"2019","unstructured":"Schmidtke C, Tiede S, Thelen M, K\u00e4kel\u00e4 R, Jabs S, Makrypidi G, Sylvester M, Schweizer M, Braren I, Brocke\u2010Ahmadinejad N et\u00a0al (2019) Lysosomal proteome analysis reveals that CLN3\u2010defective cells have multiple enzyme deficiencies associated with changes in intracellular trafficking. J Biol Chem 294: 9592\u20139604","journal-title":"J Biol Chem"},{"key":"BFEMMM202013742_CR52","doi-asserted-by":"crossref","first-page":"e201900439","DOI":"10.26508\/lsa.201900439","volume":"2","author":"AS Selyunin","year":"2019","unstructured":"Selyunin AS, Hutchens S, McHardy SF, Mukhopadhyay S (2019) Tamoxifen blocks retrograde trafficking of Shiga toxin 1 and 2 and protects against lethal toxicosis. Life Sci Alliance 2: e201900439","journal-title":"Life Sci Alliance"},{"key":"BFEMMM202013742_CR53","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ejmech.2017.11.056","volume":"143","author":"Shagufta","year":"2018","unstructured":"Shagufta & Ahmad I (2018) Tamoxifen a pioneering drug: an update on the therapeutic potential of tamoxifen derivatives. Eur J Med Chem 143: 515\u2013531","journal-title":"Eur J Med Chem"},{"key":"BFEMMM202013742_CR54","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3390\/ijms19020625","volume":"19","author":"A Somogyi","year":"2018","unstructured":"Somogyi A, Petcherski A, Beckert B, Huebecker M, Priestman DA, Banning A, Cotman SL, Platt FM, Ruonala MO, Tikkanen R (2018) Altered expression of ganglioside metabolizing enzymes results in GM3 ganglioside accumulation in cerebellar cells of a mouse model of juvenile neuronal ceroid lipofuscinosis. Int J Mol Sci 19: 625","journal-title":"Int J Mol Sci"},{"key":"BFEMMM202013742_CR55","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/emmm.201202176","volume":"5","author":"C Spampanato","year":"2013","unstructured":"Spampanato C, Feeney E, Li L, Cardone M, Lim J\u2010A, Annunziata F, Zare H, Polishchuk R, Puertollano R, Parenti G et\u00a0al (2013) Transcription factor EB (TFEB) is a new therapeutic target for Pompe disease. EMBO Mol Med 5: 691\u2013706","journal-title":"EMBO Mol Med"},{"key":"BFEMMM202013742_CR56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038310","volume":"7","author":"JF Staropoli","year":"2012","unstructured":"Staropoli JF, Haliw L, Biswas S, Garrett L, H\u00f6lter SM, Becker L, Skosyrski S, Da Silva\u2010Buttkus P, Calzada\u2010Wack J, Neff F et\u00a0al (2012) Large\u2010scale phenotyping of an accurate genetic mouse model of JNCL identifies novel early pathology outside the central nervous system. PLoS One 7: e38310","journal-title":"PLoS One"},{"key":"BFEMMM202013742_CR57","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0960-0760(01)00066-8","volume":"77","author":"TL Taras","year":"2001","unstructured":"Taras TL, Wurz GT, DeGregorio MW (2001) In vitro and in\u00a0vivo biologic effects of Ospemifene (FC\u20101271a) in breast cancer. J Steroid Biochem Mol Biol 77: 271\u2013279","journal-title":"J Steroid Biochem Mol Biol"},{"key":"BFEMMM202013742_CR58","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1091\/mbc.e02-01-0031","volume":"13","author":"J Vesa","year":"2002","unstructured":"Vesa J, Chin MH, Oelgeschl\u00e4ger K, Isosomppi J, DellAngelica EC, Jalanko A, Peltonen L (2002) Neuronal ceroid lipofuscinoses are connected at molecular level: interaction of CLN5 protein with CLN2 and CLN3. Mol Biol Cell 13: 2410\u20132420","journal-title":"Mol Biol Cell"},{"key":"BFEMMM202013742_CR59","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00043426-200005000-00010","volume":"22","author":"AW Walter","year":"2000","unstructured":"Walter AW, Gajjar A, Reardon DA, Thompson SJ, Langston JW, Jones\u2010Wallace D, Kun LE, Heideman RL (2000) Tamoxifen and carboplatin for children with low\u2010grade gliomas: a pilot study at St. Jude Children\u2019s Research Hospital. J Pediatr Hematol Oncol 22: 247\u2013251","journal-title":"J Pediatr Hematol Oncol"},{"key":"BFEMMM202013742_CR60","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1093\/hmg\/ddy248","volume":"27","author":"RWD Welford","year":"2018","unstructured":"Welford RWD, M\u00fchlemann A, Garzotti M, Rickert V, Groenen PMA, Morand O, \u00dc\u00e7eyler N, Probst MR (2018) Glucosylceramide synthase inhibition with lucerastat lowers globotriaosylceramide and lysosome staining in cultured fibroblasts from Fabry patients with different mutation types. Hum Mol Genet 27: 3392\u20133403","journal-title":"Hum Mol Genet"},{"key":"BFEMMM202013742_CR61","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jsbmb.2005.06.027","volume":"97","author":"GT Wurz","year":"2005","unstructured":"Wurz GT, Read KC, Marchisano\u2010Karpman C, Gregg JP, Beckett LA, Yu Q, Degregorio MW (2005) Ospemifene inhibits the growth of dimethylbenzanthracene\u2010induced mammary tumors in Sencar mice. J Steroid Biochem Mol Biol 97: 230\u2013240","journal-title":"J Steroid Biochem Mol Biol"},{"key":"BFEMMM202013742_CR62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-018-1227-0","volume":"9","author":"B Zhitomirsky","year":"2018","unstructured":"Zhitomirsky B, Yunaev A, Kreiserman R, Kaplan A, Stark M, Assaraf YG (2018) Lysosomotropic drugs activate TFEB via lysosomal membrane fluidization and consequent inhibition of mTORC1 activity. Cell Death Dis 9: 1\u201315","journal-title":"Cell Death Dis"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/emmm.202013742.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.15252\/emmm.202013742","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.15252\/emmm.202013742\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.embopress.org\/doi\/pdf\/10.15252\/emmm.202013742","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/emmm.202013742.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T06:36:16Z","timestamp":1779086176000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.15252\/emmm.202013742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,19]]},"references-count":62,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10,7]]}},"alternative-id":["BFEMMM202013742"],"URL":"https:\/\/doi.org\/10.15252\/emmm.202013742","relation":{},"ISSN":["1757-4676","1757-4684"],"issn-type":[{"value":"1757-4676","type":"print"},{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,19]]},"assertion":[{"value":"19 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"EMMM202013742"}}